Abstract
This is the first study to assess human health risks due to the exposure of ‘repurposed’ pharmaceutical drugs used to treat Covid-19 infection. The study used a six-step approach to determine health risk estimates. For this, consumption of pharmaceuticals under normal circumstances and in Covid-19 infection was compiled to calculate the predicted environmental concentrations (PECs) in river water and in fishes. Risk estimates of pharmaceutical drugs were evaluated for adults as they are most affected by Covid-19 pandemic. Acceptable daily intakes (ADIs) are estimated using the no-observed-adverse-effect-level (NOAEL) or no observable effect level (NOEL) values in rats. The estimated ADI values are then used to calculate predicted no-effect concentrations (PNECs) for three different exposure routes (i) through the accidental ingestion of contaminated surface water during recreational activities only, (ii) through fish consumption only, and (iii) through combined accidental ingestion of contaminated surface water during recreational activities and fish consumption. Higher risk values (hazard quotient, HQ: 337.68, maximum; 11.83, minimum) were obtained for the combined ingestion of contaminated water during recreational activities and fish consumption exposure under the assumptions used in this study indicating possible effects to human health. Amongst the pharmaceutical drugs, ritonavir emerged as main drug, and is expected to pose adverse effects on r human health through fish consumption. Mixture toxicity analysis showed major risk effects of exposure of pharmaceutical drugs (interaction-based hazard index, HI int : from 295.42 (for lopinavir + ritonavir) to 1.20 for chloroquine + rapamycin) demonstrating possible risks due to the co-existence of pharmaceutical in water. The presence of background contaminants in contaminated water does not show any influence on the observed risk estimates as indicated by low HQ add values (<1). Regular monitoring of pharmaceutical drugs in aquatic environment needs to be carried out to reduce the adverse effects of pharmaceutical drugs on human health.
Keywords: Covid-19; Novel coronavirus; PECs; Pharmaceuticals; Risk estimation; Rivers.
【저자키워드】 COVID-19, Pharmaceuticals, Novel coronavirus, PECs, Risk estimation, Rivers., 【초록키워드】 pandemic, Chloroquine, COVID-19 pandemic, Lopinavir, Ritonavir, Infection, drugs, risk, Toxicity, drug, Surface water, Novel coronavirus, PECs, activity, adverse effects, Rapamycin, Health, COVID-19 infection, novel, estimate, estimates, Concentration, Analysis, water, adverse effect, Consumption, acceptable daily intake, lopinavir + ritonavir, mixture, RATs, maximum, treat, ingestion, minimum, assumption, aquatic environment, pharmaceutical, Effect, approach, Quotient, contaminated surface, contaminant, predicted, affected, carried, indicated, evaluated, determine, reduce, expected, calculate, NOAEL, Regular, used to calculate, 【제목키워드】 Infection, drug, Health, potential risk, treat, identify, hypothetical, Can,